NEOPLASMS

This early-phase study tests a drug called zanidatamab in 10 adults with advanced HER2-positive solid tumors (like endometrial, bladder, or pancreatic cancer) that have worsened after at least one prior treatment. Participants receive the drug by IV every two weeks. The main goal…

This study looks at whether adding a mix of nutritional supplements (spirulina, bifidobacterium, fish oil, grape seed, blueberry, and ganoderma spore oil) to standard steroid treatment can help people with severe lung inflammation caused by cancer immunotherapy. About 60 adults w…

This study tests a new vaccine (TriAdeno) plus an immune-boosting drug (N-803) in men with early-stage prostate cancer who are currently just monitoring their cancer. The goal is to see if this combination can stop tumors from growing and reduce the need for more aggressive treat…

This study tests an experimental drug called LRK-4189, given alone or with standard chemotherapy, in adults with advanced solid tumors (especially colorectal cancer) that have worsened after prior treatment. The main goal is to see if the drug is safe and tolerable. About 120 par…

This study tests a new imaging agent called 68Ga-SFB6-ZN01, which attaches to a protein found on many cancer cells but rarely on healthy cells. About 98 adults with confirmed or suspected cancer will receive one injection and have a PET/CT scan. The goal is to see if the agent is…

This study tests a free online program called Finding My Way-UK for people who finished cancer treatment within the past year. The program includes six short modules on topics like managing emotions, body image, and social support. Researchers want to see if it's easy to use and …

This study follows 100 young cancer patients (ages 0-18) who freeze their ovarian tissue before starting cancer treatment. The goal is to see how safe and effective this method is for preserving their ability to have children in the future. Researchers will track pregnancy rates …

This study tests a new, non-invasive imaging tool called LC-OCT that takes detailed pictures of the skin. Researchers want to see if it can accurately diagnose basal cell carcinoma, the most common skin cancer, without needing a biopsy. About 297 adults who already had LC-OCT sca…

This study looks at where 300 cancer patients treated at Delafontaine Hospital live and how long it takes them to get there. By mapping home addresses and travel methods, researchers hope to uncover social and transportation barriers to care. The goal is to improve support and re…